Albendazole

Verify with FDA CVM →

367 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
367
Total Reports
161
Deaths Reported
4390.0%
Death Rate

Active Ingredients

Albendazole

Administration Routes

OralUnknownIntrauterineTopicalSubcutaneous

Species Affected

Cattle 177
Sheep 66
Unknown 52
Goat 30
Dog 29
Chicken 2
Human 2
Buffalo 2
Other Rodents 1
Turkey 1

Most Affected Breeds

Mixed (Cattle) 87
Unknown 59
Cattle (other) 45
Sheep (unknown) 40
Aberdeen Angus 20
Goat (unknown) 19
Cattle (unknown) 8
Katahdin 7
Dog (unknown) 6
Crossbred Bovine/Cattle 5

Most Reported Reactions

Death 109
Lack of efficacy (bacteria) - NOS 30
Lack of efficacy - NOS 28
Anorexia 19
INEFFECTIVE, WORMS NOS 18
Diarrhoea 17
Unexplained death 16
Overdose 16
Lethargy (see also Central nervous system depression in 'Neurological') 16
INEFFECTIVE, WORMS 16
No sign 15
Lack of efficacy (endoparasite) - trematode 14

Outcome Breakdown

Outcome Unknown
164 (42.1%)
Died
158 (40.5%)
Recovered/Normal
28 (7.2%)
Ongoing
25 (6.4%)
Euthanized
9 (2.3%)
Recovered with Sequela
6 (1.5%)

Data Summary

Metric Value
Total adverse event reports 367
Reports involving death 161
Case-fatality rate (reported events) 4390.0%
Distinct species in reports 10
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Albendazole Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 367 adverse event reports referencing Albendazole, including 161 reports in which the animal died — a 4390.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Albendazole. Reported administration routes include Oral, Unknown, Intrauterine, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Albendazole reports are Cattle (177 reports), Sheep (66 reports), Unknown (52 reports), with Cattle accounting for the largest share. Within those species, Mixed (Cattle) (87), Unknown (59), Cattle (other) (45) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Albendazole are Death (109), Lack of efficacy (bacteria) - NOS (30), Lack of efficacy - NOS (28), Anorexia (19). Of the 390 reports with a coded outcome, Outcome Unknown is the leading category at 42.1%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Albendazole.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial